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Abstract
Background: A number of case-control studies were conducted to investigate the association of SULT1A1 R213H
polymorphisms with colorectal cancer (CRC) in humans. But the results were not always consistent. We performed a meta-
analysis to examine the association between the SULT1A1 R213H polymorphism and CRC.
Methods and Findings: Data were collected from the following electronic databases: PubMed, Elsevier Science Direct,
Excerpta Medica Database, and Chinese Biomedical Literature Database, with the last report up to September 2010. A total
of 12 studies including 3,549 cases and 5,610 controls based on the search criteria were involved in this meta-analysis.
Overall, no significant association of this polymorphism with CRC was found (H versus R: OR=1.04, 95%CI=0.94–1.16,
P=0.46; HR+HH versus RR: OR=1.01, 95%CI=0.92–1.11, P=0.81; HH versus RR+HR: OR=1.01, 95%CI=0.74–1.38, P=0.95;
HH versus RR: OR=1.00, 95%CI=0.77–1.31, P=0.98; HR versus RR: OR=1.01, 95%CI=0.92–1.11, P=0.86). In subgroup
analysis, we also did not find any significant association in Cauasians (H versus R: OR=1.02, 95%CI=0.92–1.15, P=0.68;
HR+HH versus RR: OR=0.99, 95%CI=0.91–1.09, P=0.90; HH versus RR+HR: OR=1.01, 95%CI=0.73–1.39, P=0.97; HH versus
RR: OR=0.99, 95%CI=0.75–1.31, P=0.94; HR versus RR: OR=0.99, 95%CI=0.90–1.09, P=0.85). The results were not
materially altered after the studies which did not fulfill Hardy-Weinberg equilibrium were excluded (H versus R: OR=1.06,
95%CI=0.95–1.19, P=0.31; HR+HH versus RR: OR=1.03, 95%CI=0.93–1.13, P=0.56; HH versus RR+HR: OR=1.10,
95%CI=0.78–1.56, P=0.57; HH versus RR: OR=1.09, 95%CI=0.83–1.44, P=0.53; HR versus RR: OR=1.02, 95%CI=0.92–
1.13, P=0.75).
Conclusion: This meta-analysis demonstrates that there is no association between the SULT1A1 R213H polymorphism and
CRC.
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Introduction
Colorectal cancer (CRC) is cancer of the colon or rectum, and it
is equally common in men and women. With 655,000 deaths
worldwide per year, it is the third leading cause of cancer-related
death in the world [1,2]. In 2010, there were 142,570 new CRC
cases and 51,370 deaths from CRC in the United States [2].
Currently, CRC is a major public health burden in many
countries. Thus an understanding of the causes of this disease is an
area of intense interest. Current evidence supports an important
role for genetics in determining risk for CRC [3].
Sulfotransferases (SULTs) play an important role in normal
physiological process and malignant transformation [4]. In
humans, there are three members of the phenol sulfotransferase
family (SULT1A1, SULT1A2, and SULT1A3). SULT1A1 is
expressed in the liver as well as in many extrahepatic tissues
including colonic mucosa, and is an component in the detoxifi-
cation pathway of numerous xenobiotics [5,6]. It plays an
important role in the metabolism and bioactivation of many
dietary and environmental mutagens, including heterocyclic
amines implicated in carcinogenesis of colorectal and other
cancers [7,8]. Hence, SULT1A1 gene may be a good candidate
for genetics studies on CRC.
The SULT1A1 gene is located on chromosome 16p12.1-p11.2
[9]. A polymorphism (R213H) in the SULT1A1 gene has been
identified in the coding region at nucleotide 638 (a G to A
transition). This base change results in a change in the amino acid
sequence from arginine to histidine (Arg213His), leading to a
decrease in enzymatic activity [10].
Since its discovery in 1997, this polymorphism has attracted
widespread attention, and a number of case-control studies were
conducted to investigate the association of this polymorphism with
CRC in humans [11–24]. But the results are not always consistent.
There are several possible explanations for this discordance, such
as small sample size, ethnic background, uncorrected multiple
hypothesis testing, and publication bias. Meta-analysis is a
statistical procedure for combining the results of several studies
to produce a single estimate of the major effect with enhanced
precision [25]. It has become important in cancer genetics because
of rapid increases in the number and size of datasets. The aim of
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e19127the present study is to perform a comprehensive meta-analysis to
evaluate the association between the SULT1A1 R213H polymor-
phism and CRC.
Methods
Search strategy
In this meta-analysis, we performed an exhaustive search on
studies that examined the association of the SULT1A1 gene
polymorphisms with CRC. Data were collected from the following
electronic databases: Pubmed, Elsevier Science Direct, Excerpta
Medica Database (Embase), and Chinese Biomedical Literature
Database (CBM). We searched the articles using the search terms
‘‘sulfotransferase’’, ‘‘SULT’’, ‘‘SULT1A1’’, ‘‘colorectal’’, ‘‘colon’’,
‘‘rectum’’, and ‘‘colorectum’’. Additional studies were identified by
a hand search of references of original studies and review articles
on the association between the SULT1A1 R213H polymorphism
and CRC. No language restrictions were applied. A study was
included in the current meta-analysis if (1) it was published up to
September, 2010; (2) it was a case-control study of the SULT1A1
R213H polymorphism and CRC. We excluded the study in which
family members were studied. When there were multiple studies
from the same population, only the largest study was included.
Furthermore, two investigators independently searched the
electronic databases. An independent PubMed search was done
(by Zhou P and Zhang C) with the same method. An independent
Elsevier Science Direct search was done (by Lv GQ and Yu XM)
with the same method. An independent Embase search was done
(by Gu YL and Li JP) with the same method. An independent
CBM search was done (by Lv GQ and Yu XM) with the same
method. References in original studies and review articles were
reviewed (by Gu YL and Li JP) to identify additional studies.
Data extraction
Two investigators (Zhou P and Zhang C) independently
extracted data and reached consensus on the following character-
istics of the selected studies: the first author’s name, year of
publication, source of publication, ethnicity, number of cases and
controls, and available allele and genotype frequencies informa-
tion. If original data was unavailable in articles, a request for
original data was sent to the corresponding author.
Statistical analysis
The strength of association between the SULT1A1 R213H
polymorphism and CRC was accessed by calculating odds ratio
(OR) with 95% confidence interval (CI). We evaluated the allele
contrast (H versus R), the codominant model (HH versus RR, HR
versus RR), the dominant model (HR+HH versus RR) and the
recessive model (HH versus RR+HR), respectively. The hetero-
geneity between the studies was assessed by the Chi square-test
based Q-statistic [26]. A significant Q-statistic (P,0.10) indicated
heterogeneity across studies. We also measured the effect of
heterogeneity by another measure, I
2=100%6(Q-df)/Q [27].
The pooled OR was calculated by a fixed effect model (using the
Mantel-Haenszel method) or a random effect model (using the
DerSimonian-Laird method) according to the heterogeneity
among studies [28,29]. The potential publication bias was
estimated using Egger’s linear regression test by visual inspection
of the Funnel plot [30]. In addition, a Chi square-test was used to
determine if observed frequency of genotype in control population
conformed to Hardy-Weinberg equilibrium (HWE) expectations.
Analyses were performed using the software Review Manager 4.2
(Cochrane Collaboration, http://www.cc-ims.net/RevMan/
relnotes.htm/) and Stata version 10 (StataCorp LP, College
Station, Texas, USA). A P value less than 0.05 was considered
statistically significant, and all the P values were two sided.
Results
Characteristics of eligible studies
Characteristics of studies included in the current meta-analysis
are presented in Table 1 [11–22]. There were 2619 papers
relevant to the searching terms (Pubmed: 139; Elsevier Science
Direct: 2220; Embase: 230; CBM: 30). The study selection process
is shown in Figure 1. A total of 14 studies examined the association
between the SULT1A1 R213H polymorphism and CRC [11–24].
Of these, 2 were excluded (the data of 1 study was unavailable, 1
Table 1. Characteristics of studies included in the meta-analysis.*
ID Study Year Ethnic group
Sample size (Frequency of H
allele, %)
OR (95%CI) for H
versus R allele
Hardy-Weinberg
equilibrium of
genotype of control
Case Control
1 Cotterchio et al. [11] 2008 mainly Caucasian 834(31.35) 1249(32.78) 0.936(0.820–1.070) 0.078
2 Lilla et al. [12] 2007 Caucasian 504(35.61) 603(34.91) 1.031(0.866–1.229) 0.178
3 Chen et al. [13] 2006 Asian 140(8.93) 343(6.27) 1.466(0.877–2.451) 0.749
4 Gaustadnes et al. [14] 2006 Caucasian 230(37.39) 540(32.69) 1.230(0.980–1.544) NA
5 Sun et al. [15] 2005 Caucasian 109(48.17) 666(37.31) 1.561(1.171–2.082) 0.478
6 Landi et al. [16] 2005 Caucasian 361(26.59) 320(26.88) 0.986(0.775–1.254) 0.011
7 Sterjev et al. [17] 2005 Caucasian 100(27.00) 200(36.75) 0.637(0.439–0.924) 0.034
8 Pereira et al. [18] 2005 Brazilian 42(36.90) 100(33.00) 1.188(0.697–2.022) 0.960
9 Sachse et al. [19] 2002 Caucasian 490(34.39) 593(32.12) 1.107(0.925–1.325) 0.734
10 Nowell et al. [20] 2002 Caucasian 130(37.31) 301(42.36) 0.801(0.601–1.092) 0.815
11 Wong et al. [21] 2002 Caucasian 383(30.94) 402(32.09) 0.948(0.766–1.173) 0.082
12 Bamber et al. [22] 2001 Caucasian 226(34.51) 293(32.08) 1.116(0.860–1.447) 0.621
*OR: odds ratio; CI: confidence interval; NA: not available.
doi:10.1371/journal.pone.0019127.t001
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the current meta-analysis [11–22].
12 studies consisted of 10 Caucasian, 1 Asian and 1 Brazilian.
The allele and the genotype frequencies of the SULT1A1 R213H
polymorphism were extracted from 11 studies. But only allele
frequency was extracted from the study by Gaustadnes et al. [14].
Therefore, examining the contrast of HH versus RR, HR versus
RR, HR+HH versus RR, and HH versus RR+HR, the meta-
analysis was performed with 11 studies overall, and 9 studies
Caucasian. Examining the contrast of H allele versus R allele,
meta-analysis was performed with 12 studies overall, and 10
studies Caucasian.
The results of HWE test for the distribution of the genotype in
control population are shown in Table 1. Two studies were not in
HWE in eligible studies [16,17]. It was unavailable for one study
to perform HWE test [14].
Meta-analysis
The main results of this meta-analysis and the heterogeneity test
are shown in Table 2.
Analysis in overall population
The association between the SULT1A1 R213H polymorphism
and CRC was investigated in 12 studies with a total of 3,549 cases
and 5,610 controls. We detected significant between-study
heterogeneity in the contrasts of H versus R, HH versus RR+HR,
and HH versus RR. We found no association between the
SULT1A1 R213H polymorphism and CRC in overall population
(H versus R: OR=1.04, 95%CI=0.94–1.16, P=0.46; HR+HH
versus RR: OR=1.01, 95%CI=0.92–1.11, P=0.81; HH versus
RR+HR: OR=1.01, 95%CI=0.74–1.38, P=0.95; HH versus
RR: OR=1.00, 95%CI=0.77–1.31, P=0.98; HR versus RR:
OR=1.01, 95%CI=0.92–1.11, P=0.86).
Analysis in HWE population
Meta-analysis was carried out in those studies fulfilling HWE.
The meta-analysis included 9 studies (2,858 cases and 4,550
controls). The Q-test of heterogeneity was significant in the
contrasts of H versus R, HH versus RR+HR, and HH versus RR.
We did not detect an association of the SULT1A1 R213H
polymorphism and CRC in HWE population (H versus R:
OR=1.06, 95%CI=0.95–1.19, P=0.31; HR+HH versus RR:
OR=1.03, 95%CI=0.93–1.13, P=0.56; HH versus RR+HR:
OR=1.10, 95%CI=0.78–1.56, P=0.57; HH versus RR:
OR=1.09, 95%CI=0.83–1.44, P=0.53; HR versus RR:
OR=1.02, 95%CI=0.92–1.13, P=0.75).
Analysis in Caucasian population
The meta-analysis included 10 studies (3,367 cases and 5,167
controls) in Caucasian population. The Q-test of heterogeneity
was significant in the contrasts of H versus R, HH versus RR+HR,
and HH versus RR. No statistically significant association was
established for the SULT1A1 R213H polymorphism in Caucasian
population (H versus R: OR=1.02, 95%CI=0.92–1.15, P=0.68;
HR+HH versus RR: OR=0.99, 95%CI=0.91–1.09, P=0.90;
HH versus RR+HR: OR=1.01, 95%CI=0.73–1.39, P=0.97;
HH versus RR: OR=0.99, 95%CI=0.75–1.31, P=0.94; HR
versus RR: OR=0.99, 95%CI=0.90–1.09, P=0.85).
Evaluation of publication bias
The shapes of the funnel plots did not reveal any evidence of
obvious asymmetry (funnel plots not shown). Meanwhile, we
Figure 1. Flow diagram of the study selection process.
doi:10.1371/journal.pone.0019127.g001
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regression test. The intercept a provides a measure of asymmetry,
and the larger its deviation from zero the more pronounced the
asymmetry. The results of Egger’s linear regression test are shown
in Table 3. It was shown that there was no publication bias for all
comparisons.
Discussion
Multiple lines of evidence support an important role for genetics
in determining risk for cancer, and association studies are
appropriate for searching susceptibility genes involved in cancer
[31]. Nevertheless, small sample sized association studies lack
statistical power and have resulted in apparently contradicting
findings [32]. Meta-analysis is a means of increasing the effective
sample size under investigation through the pooling of data from
individual association studies, thus enhancing the statistical power
of the analysis for the estimation of genetic effects [25]. In the
current meta-analysis, on the basis of 12 case-control studies
providing data on the SULT1A1 R213H polymorphism and CRC
involving 3,549 cases and 5,610 controls, we did not find any
significant association between the SULT1A1 R213H polymor-
phism and CRC among overall and Caucasian populations.
Moreover, the results were not materially altered after the studies
which did not fulfill HWE were excluded. Our meta-analysis
suggests that the SULT1A1 R213H polymorphism is not
associated with CRC development. As far as we know, this is
the first meta-analysis carried out so far aimed at investigating the
association of the SULT1A1 R213H polymorphism with CRC.
SULT1A1 are associated with the detoxification and activation
of different carcinogens, and the regulation of many hormones
[7,8]. It has been observed that a G to A transition at nucleotide
638 in SULT1A1 gene causes an Arg to His substitution associated
with a low enzymatic activity [10]. Recently, studies have
suggested that SULT1A1 HH genotype was associated with an
increased risk for some cancers development, such as esophagus,
breast, and lung cancer [33–35]. These results seem to support
that low activity of SULT1A1*H allozyme lacks a protection
against dietary and/or environmental chemicals involved in the
carcinogenesis of cancer. However, our meta-analysis suggests that
the SULT1A1 R213H polymorphism is not associated with CRC
risk. The study by Raftogianis et al. [10] suggests that this
polymorphism is associated with a low enzyme activity. The
enzyme activity was measured using platelet preparations in this
study. Nevertheless, the use of platelets to determine the activity of
a specific enzyme can be misinterpreted due to the inability of the
Table 2. Meta-analysis of the association of SULT1A1 R213H polymorphism and colorectal cancer.*
Polymorphism Study Sample size
No. of
Studies Test of association
Test of
heterogeneity
Case Control OR (95%CI) Z P-value Model x
2 P-value I
2(%)
H vs R Overall 7098 11220 12 1.04(0.94–1.16) 0.75 0.46 R 25.00 0.009 56.0
HWE 5716 9100 9 1.06(0.95–1.19) 1.01 0.31 R 16.13 0.04 50.4
Caucasian 6734 10334 10 1.02(0.92–1.15) 0.41 0.68 R 22.83 0.007 60.6
HR+HH vs RR Overall 3319 5070 11 1.01(0.92–1.11) 0.24 0.81 F 8,53 0.58 0.0
HWE 2858 4550 9 1.03(0.93–1.13) 0.58 0.56 F 5.31 0.72 0.0
Caucasian 3137 4627 9 0.99(0.91–1.09) 0.12 0.90 F 5.53 0.70 0.0
HH vs RR+HR Overall 3319 5070 11 1.01(0.74–1.38) 0.07 0.95 R 37.81 ,0.0001 73.6
HWE 2858 4550 9 1.10(0.78–1.56) 0.57 0.57 R 32.46 ,0.0001 75.4
Caucasian 3137 4627 9 1.01(0.73–1.39) 0.04 0.97 R 37.34 ,0.0001 78.6
HH vs RR Overall 1945 2999 11 1.00(0.77–1.31) 0.03 0.98 R 25.00 0.005 60.0
HWE 1648 2666 9 1.09(0.83–1.44) 0.62 0.53 R 19.24 0.01 58.4
Caucasian 1809 2641 9 0.99(0.75–1.31) 0.07 0.94 R 24.55 0.002 67.4
HR vs RR Overall 2948 4482 11 1.01(0.92–1.11) 0.18 0.86 F 10.75 0.38 6.9
HWE 2528 4028 9 1.02(0.92–1.13) 0.32 0.75 F 9.68 0.29 17.3
Caucasian 2771 4051 9 0.99(0.90–1.09) 0.19 0.85 F 7.68 0.46 0.0
*SULT1A1: sulfotransferase 1A1; vs: versus; R: random effect model; F: fixed effect model; HWE: Hardy-Weinberg equilibrium.
doi:10.1371/journal.pone.0019127.t002
Table 3. Egger’s linear regression test to measure the funnel plot asymmetric.*
Comparisons Y axle intercept: a (95%CI)
Hv sR H R +HH vs RR HH vs RR+HR HH vs RR HR vs RR
Overall 0.75(22.03,3.55) 0.48(21.29,2.25) 20.30(23.66,3.04) 20.13(22.87,2.60) 0.04(21.96,2.05)
HWE 1.67(21.07,4.43) 1.14(20.34,2.63) 0.36(23.60,4.32) 0.55(22.45,3.57) 0.37(22.02,2.76)
Caucasian 0.01(24.32,4.36) 20.74(22.94,1.45) 21.17(27.36,5.01) 21.16(26.13,3.80) 21.40(23.68,0.87)
*P.0.05; vs: versus; HWE: Hardy-Weinberg equilibrium.
doi:10.1371/journal.pone.0019127.t003
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observed [21]. Moreover, preliminary modelling studies indicate
that this polymorphism does not appear to directly affect the
binding site of the substrate or of the universal sulphonate donor
39phosphoadenosine-59-phosphosulphate (PAPS) [36]. Mean-
while, in the study performed by Ozawa et al. [37], although a
recombinant enzyme was used, differences in sulphonating
abilities were only slight, which may be explained by the
compromise in thermostability the amino acid change causes. In
addition, evdiences suggest that the SULT1A1 R213H polymor-
phism is in linkage disequilibrium with SULT1A2 N235T [38,39].
Thus, it is possible that the activity measured in their study is
attributable to SULT1A2 and SULT1A1. Further studies of the
functional implications of this polymorphism are still needed in the
future.
Several specific details merit consideration in the current meta-
analysis. Firstly, a recent meta-analysis showed that the SULT1A1
R213H polymorphism had no exact effect to increase the risk of
breast cancer, but it did increase the risk of breast cancer among
postmenopausal women [40]. Therefore, this polymorphism may
only play a role in conjunction with environmental exposures. A
more precise analysis stratified by environmental exposures could
be performed if individual data were available. Secondly, it is
worth mentioning that only 2 of the 12 studies were conducted in
non-Cauasian population in our meta-analysis. Hence, the results
of our meta-analysis indicate that there is no association between
the SULT1A1 R213H polymorphism and CRC, mainly in
Cauasian population. Thirdly, significant between-study hetero-
geneity was detected in some comparisons, and may be distorting
the meta-analysis. Fouthly, only published studies were included in
this meta-analysis, and publication bias may occur. Fifthly, our
results should be interpreted with caution because the prevalence
of the SULT1A1 R213H polymorphism may be different in
various subtypes of CRC. A analysis stratified by different subtypes
of CRC may provide a more precise result. Finally, although we
minimized the likelihood of bias by developing a detailed protocol
before initiating the study, meta-analysis remains retrospective
research that is subject to the methodological deficiencies of the
included studies.
In conclusion, our meta-analysis demonstrates that there is no
association between the SULT1A1 R213H polymorphism and
CRC, mainly in Cauasian population. To reach a definitive
conclusion, further gene-gene and gene-environment interactions
studies based on larger sample size are still needed, especially in
non-Cauasian population.
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